Urothelial carcinoma
Conditions
Interventions
Gold Standard:Pathological diagnosis results of biopsy
Index test:Single cell sequencing, urine cytology testing
Sponsors
Fudan University Affiliated Huashan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) From September 2024 to June 2025, the patient went to the urology department of Huashan Hospital to see a doctor. Before the operation, the patient was proposed to be diagnosed as bladder cancer or renal pelvis and ureter cancer, and was proposed to be treated by cystoscopy/ureteroscopy; (2) Age range: 18-85 years old, male or female not limited; (3) The patient understands and signs the informed consent form, and is willing to provide urine samples for research.
Exclusion criteria
Exclusion criteria: (1) The patient did not receive surgical treatment or underwent radical organ resection surgery; (2) The patient's clinical and pathological data is incomplete; (3) The patient refused to use their own clinical data for the analysis of this clinical study; (4) Researchers believe that there are other situations that are not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity;specificity;Positive predictive value;Negative predictive value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival, PFS;Recurrence free survival, RFS; | — |
Countries
China
Contacts
Public ContactHaowen Jiang;Chenyang Xu
Department of Urology, Huashan Hospital Affiliated to Fudan University
Outcome results
None listed